Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Teva enters Tuznue license agreement with Prestige Biopharma
8d ago
TEVA
Premium
The Fly
Teva announces FDA approval of Uzedy for bipolar I disorder
18d ago
TEVA
Premium
The Fly
Teva price target raised to $24 from $22 at BofA
19d ago
TEVA
Premium
The Fly
Teva price target raised to $26 from $23 at JPMorgan
25d ago
TEVA
Premium
The Fly
Teva put volume heavy and directionally bearish
1M ago
TEVA
Premium
Ratings
Teva Pharmaceutical: Strategic Focus and Financial Stability Drive Buy Rating
1M ago
TEVA
Premium
The Fly
Teva price target raised to $26 from $23 at UBS
1M ago
TEVA
Premium
The Fly
Teva announces presentation of data from survey of patients taking AUSTEDO XR
1M ago
TEVA
Premium
The Fly
Teva preesents 10 posters from its schizophrenia medicines portfolio
1M ago
TEVA
Premium
The Fly
Teva’s emrusolmin granted U.S. FDA Fast Track designation
2M ago
TEVA
Premium
The Fly
Teva announces FDA approval, launch of Generic Saxenda
2M ago
TEVA
Premium
The Fly
Acadia Pharmaceuticals names Katcheves Chief Business and Strategy Officer
2M ago
ACAD
TEVA
Premium
The Fly
Teva put volume heavy and directionally bearish
2M ago
TEVA
Premium
The Fly
Teva announces U.S. FDA has approved AJOVY for preventive treatment
3M ago
TEVA
Premium
The Fly
Teva management to meet with Truist
3M ago
TEVA
Premium
The Fly
Teva says targeting operating margin of 30% by 2027
3M ago
TEVA
Premium
The Fly
Teva says ‘very confident’ about growing generics business
3M ago
TEVA
Premium
The Fly
Teva reaffirms FY25 revenue view $16.8B-$17.2B, consensus $16.92B
3M ago
TEVA
Premium
The Fly
Teva reports Q2 adjusted EPS 66c, consensus 62c
3M ago
TEVA
Premium
The Fly
Teva says ‘on track’ for 30% operating profit margin by 2027
3M ago
TEVA
Premium
The Fly
Teva price target lowered to $29 from $30 at Piper Sandler
3M ago
TEVA
Premium
Ratings
Teva Pharmaceutical’s Favorable Position in IRA Negotiations Drives Buy Rating
3M ago
TEVA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
